The Technical Analyst
Azenta, Inc. [AZTA]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies
Azenta, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-1.13% $51.50
America/New_York / 25 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 871.90 mill |
| EPS: | -0.320 |
| P/E: | -160.94 |
| Earnings Date: | May 07, 2024 |
| SharesOutstanding: | 55.77 mill |
| Avg Daily Volume: | 0.452 mill |
| RATING 2024-04-25 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -160.94 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -4.87x |
| Company: PE -160.94 | industry: PE 33.06 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-7.90 (-115.34%) $-59.40 |
| Date: 2024-04-25 |
| Expected Trading Range (DAY) |
|---|
|
$ 49.86 - 53.15 ( +/- 3.19%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-01 | Joseph Jason | Sell | 1 000 | Common |
| 2024-03-07 | Joseph Jason | Sell | 1 000 | Common |
| 2024-03-07 | Joseph Jason | Sell | 4 000 | Common |
| 2024-03-07 | Joseph Jason | Sell | 4 000 | Common |
| 2024-03-08 | Joseph Jason | Sell | 4 000 | Common |
| INSIDER POWER |
|---|
| 18.22 |
| Last 91 transactions |
| Buy: 295 223 | Sell: 171 463 |
Forecast:
16:00 - $51.50
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $51.50
Forecast 2: 16:00 - $51.50
Forecast 3: 16:00 - $51.50
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $51.50 (-1.13% ) |
| Volume | 0.343 mill |
| Avg. Vol. | 0.452 mill |
| % of Avg. Vol | 75.71 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For AZTA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $63.74 | N/A | Active |
|---|
AZTA
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Last 10 Buy Signals
Latest Press Releases
2024-04-01 16:15:00 - Press Release
Azenta Publishes Its 2023 Environmental, Social, & Governance (esg) Report
Burlington, mass. , april 1, 2024 /prnewswire/ -- azenta, inc. (nasdaq: azta) today announced the publication of its annual environmental, social, & governance ("esg") report, highlighting the company's ongoing commitment to advancing its strategy and actions aligned with key esg priorities.
2024-04-01 16:05:00 - Press Release
Azenta To Participate In The 23rd Annual Needham Virtual Healthcare Conference
Burlington, mass. , april 1, 2024 /prnewswire/ -- azenta, inc. (nasdaq: azta) today announced that company management will participate in the 23rd annual needham virtual healthcare conference, on monday, april 8, 2024, which includes a presentation beginning at 12:45 pm et.
2024-03-12 08:00:00 - Press Release
Azenta To Participate In The Virtual Keybanc Life Sciences & Medtech Investor Forum
Burlington, mass. , march 12, 2024 /prnewswire/ -- azenta, inc. (nasdaq: azta) today announced that company management will participate in virtual keybanc life sciences & medtech investor forum on tuesday, march 19, 2024, which includes a presentation beginning at 12:45 pm et.
2024-02-07 16:05:00 - Press Release
Azenta Reports First Quarter Results For Fiscal 2024, Ended December 31, 2023
Burlington, mass. , feb. 7, 2024 /prnewswire/ -- azenta, inc. (nasdaq: azta) today reported financial results for the first quarter ended december 31, 2023.
2024-02-02 08:00:00 - Press Release
Azenta Launches The Bioarc™ Ultra, A Breakthrough, Automated Solution For Efficient, Eco-friendly Ultracold Sample Management
Burlington, mass. , feb. 2, 2024 /prnewswire/ -- azenta, inc. (nasdaq: azta) today announced the launch of the bioarc™ ultra (the "ultra"), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories.
Latest News
2024-02-07 22:05:03 - Seeking Alpha
Azenta, Inc. (AZTA) Q1 2024 Earnings Call Transcript
2024-02-06 10:46:43 - MarketBeat
5 medical stocks growing earnings by triple digits
While most of the market focuses on hyper-growth technology stocks rewarded by Wall Street as long as they mention the word "artificial intelligence" in their earnings calls, the reality is that the fundamentals now favor other (safer) areas of the economy.
2023-12-29 18:35:41 - CNBC Television
Final Trade: DISH, GLD, EWJ and AZTA
2023-11-14 23:17:03 - Zacks Investment Research
3 Stocks to Watch After Impressive Earnings Beats
In a somewhat quiet earnings lineup this week, several stocks stand out after posting strong quarterly results on Monday.
2023-11-13 20:36:08 - Seeking Alpha
Azenta, Inc. (AZTA) Q4 2023 Earnings Call Transcript
Azenta, Inc. (NASDAQ:AZTA ) Q4 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Sara Silverman - Head of IR Steve Schwartz - President and CEO Herman Cueto - CFO Conference Call Participants David Saxon - Needham Jacob Johnson - Stephens Andrew Cooper - Raymond James Paul Knight - KeyBanc Vijay Kumar - Evercore ISI Yuan Zhi - B. Riley Operator Thank you, and welcome to the Azenta Q4 2023 Financial Results.
2023-11-13 17:01:00 - Market Watch
Azenta shares jump on Q4 results, buyback plans
Shares of Azenta Inc. AZTA, +0.59% jumped 11.9% after hours on Monday after the life-sciences company reported fourth-quarter results that beat expectations and announced plans to buy back an extra $500 million in stock in fiscal 2024. The company — whose products and services help researchers store, handle and process chemical and biological samples — reported net income of $3.4 million, or 6 cents a share, compared with a loss of $20.8 million, or 28 cents a share, in the same quarter last year.
2023-11-09 15:07:28 - Seeking Alpha
Azenta: Life Science Play Suffers A Bad Diagnosis
Azenta, Inc., formerly Brooks Automation, sold its semiconductor business and subsequently became a pure play life science business. Azenta's shares have declined significantly and its valuation is still supported by net cash holdings. However, Azenta is not profitable, making it difficult to be optimistic about its shares.
2023-10-12 08:55:46 - The Motley Fool
You Can't Control Activist Investors, but You Can Control What You Do About Them
Having activist investors at a company can lead to big changes. Azenta is dealing with an activist's call for better performance as it puts a giant cash hoard to work.
2023-09-30 09:04:14 - CNBC
Activist Politan Capital engages with Azenta. Here's how the firm may boost shareholder value
Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.
2023-09-08 16:05:00 - PRNewsWire
Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
BURLINGTON, Mass. , Sept. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference in New York, NY, on Wednesday, September 13, 2023, which includes a presentation beginning at 2:55 pm ET.